State Budgetary Healthcare Institution «Saint-Petersburg Clinical Scientific and practical center of specialized types of medical care (oncological)», Saint-Petersburg, Russian Federation
A delegation of the St. Petersburg Oncocentre visited our Institute in June 2018, for the purpose of establishing future professional cooperation. The successful initial contact was followed by mutual visits of professionals. A formal agreement between our Institutes was finalized in March 2019 in St. Petersburg.
The State Budgetary Institution of Higher Professional Education «Voronezh State Medical University named after N.N. Burdenko», Voronezh, Russian Federation
The bilateral partnership began in 2014 with the aim of strengthening cooperation between the countries in the field of health and medical education. The renewal of the cooperation agreement took place in February 2019.
Regional budgetary healthcare institution of Sverdlovsk region “Sverdlovsk Regional Oncology Centre”, Yekaterinburg, Russian Federation
A delegation of health professionals visited our Institute in October 2018, to discuss the possible cooperation opportunities with the management of our Institutes. During the meeting the parties agreed to the signing of a Memorandum of Understanding.
State Organisation «Grigoriev Medical Radiology NAMS of Ukraine», Kharkiv, Ukraine
A formal agreement was signed between the National Institute of Oncology and the State Organisation «Grigoriev Medical Radiology NAMS of Ukraine» in June 2018, for a joint non-profit scientific study to be established. The responsible coordinator from our Institute is Dr. Zoltán Novák, MD, Ph.D.; Department Head.
Ministry of Health and Medical Education, Tehran, Islamic Republic of Iran
A cooperation agreement was signed between the National Institute of Oncology and the Ministry of Health and Medical Education of the Islamic Republic of Iran with the aim to strengthen the relationship between the two countries, as well as to establish a professional and scientific cooperation in different areas of cancer prevention.
Oncopathology Research Centre, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran
A cooperation agreement was signed between the National Institute of Oncology and Oncopathology Research Centre, Iran University of Medical Sciences with the aim to strengthen the relationship between the two countries, as well as to establish a technical and scientific cooperation in various areas of cancer research.
National Cancer Institute (NCI) – Vilnius, Lithuania
The bilateral partnership started in 2013 with a professional visit to our Institute by the Lithuanian National Cancer Institute’s senior delegation. The ceremonial signing of the cooperation agreement in the field of cancer treatment, research and education took place in 2014, in Vilnius.
Deutsches Krebsforschungszentrum (DKFZ) – Heidelberg, Germany
In 2013, within the framework of the EurocanPlatform project an Agreement for Cooperation was implemented between the German Cancer Research Centre (Deutsches Krebsforschungszentrum) and NIO that laid the foundation for a long-term epidemiological cooperation. The first “fruit” of this cooperation is a study entitled: “Trends in uptake and utilization of sentinel lymph node dissection among breast cancer patients – an international comparative study among EUROCAN Platform members”. Additional scientific collaborations are in place between DKFZ’s redox biology research unit and our Institute’s Molecular Immunology and Toxicology Department (MITO), which is hallmarked by several joint publications.
University of Medicine and Pharmacy – Tirgu Mureş, Romania
In 2006, the University of Medicine and Pharmacy of Tirgu Mureş (MOGYE) received authorization from the Hungarian Accreditation Committee to establish a PhD programme in the field of medical sciences together with NIO as a co-partner. As a result, the Postgraduate Medical Faculty in Budapest was set up consisting of eight departments led by Prof. Dr. Miklós Kásler. The PhD education has been continuous since 2006, and is open for both Transylvanian and Hungarian colleagues. So far, twenty Hungarian students have earned their PhD in the programme.
Hungarian-Bavarian Intergovernmental Agreement
In 2003, under the Hungarian-Bavarian Intergovernmental Agreement our Institute’s Cancer Registry established contacts, first with the Cancer Registry in Erlangen, then in Munich and Giessen. The collaboration is still ongoing with these centres. The multiple specialist visits and continuous exchange of information between these institutions greatly contributed to the development of our Institute’s Cancer Registry. The last visit took place in 2008, when expert Dr. Imre Boncz travelled to Erlangen. Currently, the collaboration is mainly focused on the exchange of information and documentations.
Liaoning Cancer Hospital – Shenyang, China
Since 2002, within the framework of “Chinese Cooperation Agreement”, our Institute has bilateral relations with the Liaoning Cancer Hospital (Shenyang). The senior level mutual visits and presentations were the first steps of this cooperation. At first, our Institute welcomed the hospital’s top management and laid the foundation of a professional cooperation, which was further developed during our delegation’s visits to China. In 2008 and 2013, we hosted the Chinese delegation, and in 2010 and 2014, the former Director General of our Institute, Prof. Dr. Miklós Kásler and the then Deputy Director, Prof. Dr. Csaba Polgár as well as Prof. Dr. János Fodor Professor Emeritus travelled to our Chinese partners to negotiate an extension for the areas for cooperation. Currently, we are working together mainly in the field of radiation therapy. In addition to the ongoing professional exchanges, we hosted a Chinese PhD student who developed her PhD thesis at our Institute.
Our Institute is in close cooperation with the National Cancer Institute and the MD Anderson Cancer Center in the United States. NIO also developed joint research projects with various American institutes in the breast and colon cancer domains.
We are in close cooperation with the Karolinska Institute in Stockholm (since 2008), primarily in the form of expert visits, exchange of scientific results and participating in meetings. The director of the world-famous Cancer Center of the KI, Professor Dr. Ulrik Ringborg is the member of our Institute’s International Scientific Advisory Board.